ArticleActa pharmacologica Sinica2026
Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase.
Lei Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.